A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2

Cited by (645)

Items 101–200 of 645

1. Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused Overview
   Rukmankesh Mehra, Kasper P. Kepp · 2021 · ACS Infectious Diseases
2. An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination
   Bülent Kantarcıoğlu, Omer Iqbal, Jeanine M. Walenga, Bruce Lewis, Joseph Lewis, Charles A. Carter, Meharvan Singh, Fabio A. Lievano, Alfonso Javier Tafur, Eduardo Ramacciotti et al. · 2021 · Clinical and Applied Thrombosis/Hemostasis
3. Determinants of COVID-19 vaccine hesitancy and resistance in Russia
   Yana M. Roshchina, Sergey Roshchin, Ksenia V. Rozhkova · 2022 · Vaccine
4. Modeling the impact of racial and ethnic disparities on COVID-19 epidemic dynamics
   Kevin C. Ma, Tigist F. Menkir, Stephen M. Kissler, Yonatan H. Grad, Marc Lipsitch · 2021 · eLife
5. Rate and Predictors of Hesitancy toward SARS-CoV-2 Vaccine among Type 2 Diabetic Patients: Results from an Italian Survey
   Federica Guaraldi, Marco Montalti, Zeno Di Valerio, Edoardo Mannucci, Besmir Nreu, Matteo Monami, Davide Gori · 2021 · Vaccines
6. Modelling COVID-19 dynamics and potential for herd immunity by vaccination in Austria, Luxembourg and Sweden
   Françoise Kemp, Daniele Proverbio, Atte Aalto, Laurent Mombaerts, Aymeric Fouquier d’Hérouël, Andreas Husch, Christophe Ley, Jorge M. Gonçalves, Alexander Skupin, Stefano Magni · 2021 · Journal of Theoretical Biology
7. Covid-19’s known unknowns
   George Davey Smith, Michael Blastland, Marcus Robert Munafo · 2020 · BMJ
8. Piecewise quadratic growth during the 2019 novel coronavirus epidemic
   Axel Brandenburg · 2020 · Infectious Disease Modelling
9. Estimating the impact of interventions against COVID-19: From lockdown to vaccination
   James Thompson, Stephen Wattam · 2021 · PLoS ONE
10. What the reproductive number R0 can and cannot tell us about COVID-19 dynamics
    Clara L. Shaw, David A. Kennedy · 2021 · Theoretical Population Biology
11. SARS-CoV-2-related mortality in a rural Latin American population
    Óscar H. Del Brutto, Aldo F. Costa, Robertino M. Mera, Bettsy Y. Recalde, Javier Arturo Bustos, Hector Hugo Garcia · 2020 · International Journal of Infectious Diseases
12. Kinetic Modelling of Epidemic Dynamics: Social Contacts, Control with Uncertain Data, and Multiscale Spatial Dynamics
    Giacomo Albi, Giulia Bertaglia, Walter Boscheri, Giacomo Dimarco, Lorenzo Pareschi, Giuseppe Toscani, Mattia Zanella · 2022 · Modeling and simulation in science, engineering & technology
13. Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China
    Hengcong Liu, Juanjuan Zhang, Jun Cai, Xiaowei Deng, Cheng Peng, Xinghui Chen, Juan Yang, Qianhui Wu, Xinhua Chen, Zhiyuan Chen et al. · 2022 · BMC Medicine
14. Learning Epidemiology by Doing: The Empirical Implications of a Spatial-SIR Model with Behavioral Responses
    Alberto Bisin, Andrea Moro · 2020 · National Bureau of Economic Research
15. Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
    R. Vignesh, E. Shankar, V. Velu, S. Thyagarajan · 2020 · Frontiers in Immunology
16. Heterogeneity in susceptibility dictates the order of epidemic models
    Christopher Rose, Andrew James Medford, Claude Franklin Goldsmith, Tejs Vegge, Joshua S. Weitz, Andrew A. Peterson · 2021 · Journal of Theoretical Biology
17. A Real-World Comparison of SARS-CoV-2 Rapid Antigen Testing versus PCR Testing in Florida
    Lao‐Tzu Allan‐Blitz, Jeffrey David Klausner · 2021 · Journal of Clinical Microbiology
18. The forgotten numbers: A closer look at COVID-19 non-fatal valuations
    Thomas J. Kniesner, Ryan S. Sullivan · 2020 · Journal of Risk and Uncertainty
19. JUE insight: Learning epidemiology by doing: The empirical implications of a Spatial-SIR model with behavioral responses
    Alberto Bisin, Andrea Moro · 2020 · Journal of Urban Economics
20. Extending susceptible-infectious-recovered-susceptible epidemics to allow for gradual waning of immunity
    Mohamed El Khalifi, Tom Britton · 2023 · Journal of The Royal Society Interface
21. Optimal control of epidemic spreading in the presence of social heterogeneity
    Giacomo Dimarco, Giuseppe Toscani, Mattia Zanella · 2022 · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences
22. Vaccination and herd immunity thresholds in heterogeneous populations
    Elamin H. Elbasha, Abba B. Gumel · 2021 · Journal of Mathematical Biology
23. Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country
    Geert Molenberghs, Marc E Buyse, Steven Abrams, Niel Hens, Philippe Beutels, Christel Faes, Geert N. Verbeke, Pierre Van Damme, Herman Goossens, Thomas Neyens et al. · 2020 · Contemporary Clinical Trials
24. Herd immunity under individual variation and reinfection
    Antonio Montalbán, Rodrigo M. Corder, M. Gabriela M. Gomes · 2022 · Journal of Mathematical Biology
25. A data-driven epidemic model with social structure for understanding the COVID-19 infection on a heavily affected Italian province
    Mattia Zanella, Chiara Bardelli, Giacomo Dimarco, Silvia Deandrea, Pietro Perotti, Mara Azzi, Silvia Figini, Giuseppe Toscani · 2021 · Mathematical Models and Methods in Applied Sciences
26. A practical guide to mathematical methods for estimating infectious disease outbreak risks
    Emma Southall, Z. Ogi-Gittins, Alexander R. Kaye, William S. Hart, Francesca A. Lovell-Read, Robin N. Thompson · 2023 · Journal of Theoretical Biology
27. The impact of host resistance on cumulative mortality and the threshold of herd immunity for SARS-CoV-2
    José Lourenço, Francesco Pinotti, Craig Thompson, Sunetra Gupta · 2020 · medRxiv
28. Four Stylized Facts about COVID-19
    Andrew G. Atkeson, Karen Kopecky, Tao A. Zha · 2020 · National Bureau of Economic Research
29. Reinfection or Reactivation of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review
    Xiujuan Tang, Salihu S. Musa, Shi Zhao, Daihai He · 2021 · Frontiers in Public Health
30. The herd-immunity threshold must be updated for multi-vaccine strategies and multiple variants
    Iraj Yadegari, Mehdi Omidi, Stacey R. Smith · 2021 · Scientific Reports
31. Pre-Vaccination Stress, Post-Vaccination Adverse Reactions, and Attitudes towards Vaccination after Receiving the COVID-19 Vaccine among Health Care Workers
    Sylwia Kałucka, Ewa Kusideł, Agnieszka Głowacka, Paulina Oczoś, Izabela Grzegorczyk-Karolak · 2022 · Vaccines
32. A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose
    Ruanne V. Barnabas, Anna Wald · 2021 · Annals of Internal Medicine
33. Analysis of Key Factors of a SARS-CoV-2 Vaccination Program: A Mathematical Modeling Approach
    David Martínez‐Rodríguez, Gilberto González‐Parra, Rafael Jacinto Villanueva · 2021 · Epidemiologia
34. Multi-generational SIR modeling: Determination of parameters, epidemiological forecasting and age-dependent vaccination policies
    Eduardo Lima Campos, Rubens Penha Cysne, Alexandre L. Madureira, Gélcio Luiz Quintella Mendes · 2021 · Infectious Disease Modelling
35. Controlling the spread of COVID-19 on college campuses
    Molly Borowiak, Fayfay Ning, Justin Pei, Sarah Zhao, Hwai-Ray Tung, Rick Durrett · 2020 · Mathematical Biosciences & Engineering
36. Features of developing SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 epidemic in the Russian Federation
    Anna Yu. Popova, Elena E. Andreeva, Elena A. Babura, С. В. Балахонов, Natalia S. Bashketova, M.V. Bulanov, N. N. Valeullina, D.V. Goryaev, Детковская Татьяна Николаевна, Elena B. Ezhlova et al. · 2021 · Russian Journal of Infection and Immunity
37. Implications of heterogeneous SIR models for analyses of COVID-19
    Glenn Ellison · 2024 · Review of Economic Design
38. Novel spatial profiles of some diffusive SIS epidemic models
    Rui Peng, Zhi‐An Wang, Guanghui Zhang, Maolin Zhou · 2023 · Journal of Mathematical Biology
39. Dynamics of SARS-CoV-2 with waning immunity in the UK population
    Thomas Crellen, Li Pi, Emma Louise Davis, Timothy M. Pollington, Tim C. D. Lucas, Diepreye Victoria Ayabina, Anna Borlase, Jaspreet Toor, Kiesha Prem, Graham Francis Medley et al. · 2021 · Philosophical Transactions of the Royal Society B Biological Sciences
40. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19)
    Irina Kislaya, Paulo Gonçalves, Marta Barreto, Rita de Sousa, Ana Cristina Garcia, Rita Matos, Raquel Guiomar, Ana Paula Rodrigues, On behalf of ISNCOVID-19 Group · 2021 · Acta Médica Portuguesa
41. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic
    Anna Yurievna Popova, В. С. Смирнов, Elena E. Andreeva, Elena A. Babura, С. В. Балахонов, Natalia S. Bashketova, Бугоркова Светлана Александровна, M.V. Bulanov, N. N. Valeullina, В. В. Ветров et al. · 2021 · Viruses
42. Seroprevalence of Antibodies against SARS-CoV-2 among the Personnel and Students of the National and Kapodistrian University of Athens, Greece: A Preliminary Report
    Ourania Tsitsilonis, Dimitrios N. Paraskevis, Evi S. Lianidou, Vassilios Pierros, Athanasios Akalestos, Efstathios Kastritis, Paraskevi Moutsatsou, Andreas Scorilas, Thomas Sphicopoulos, Evangelos Terpos et al. · 2020 · Life
43. Quantitative evaluation of infectious health care wastes from numbers of confirmed, suspected and out-patients during COVID-19 pandemic: A case study of Wuhan
    Jia Wang, Zhuqi Chen, Songlin Wang, Lie Yang, Lie Yang, Xiaolong Wu, Xinquan Zhou, Zhulei Chen · 2021 · Waste Management
44. Epidemic modeling with heterogeneity and social diffusion
    Henri Berestycki, Benoı̂t Desjardins, Joshua S. Weitz, Jean-Marc Oury · 2023 · Journal of Mathematical Biology
45. Information about herd immunity through vaccination and empathy promote COVID-19 vaccination intentions
    Stefan Pfattheicher, Michael Bang Petersen, ROBERT M. BOHM · 2020
46. The scale and dynamics of COVID-19 epidemics across Europe
    Christopher Dye, Russell C. H. Cheng, J. S. Dagpunar, Brian Gerard Williams · 2020 · Royal Society Open Science
47. Public health decisions in the COVID-19 pandemic require more than ‘follow the science’
    Thana Cristina de Campos, Eduardo A. Undurraga · 2021 · Journal of Medical Ethics
48. Mathematical modeling of COVID-19 in British Columbia: An age-structured model with time-dependent contact rates
    Sarafa Adewale Iyaniwura, Rebeca Cardim Falcão, Notice Ringa, Prince Adu, Michelle Spencer, Marsha Taylor, Caroline Colijn, Daniel Coombs, Naveed Zafar Janjua, Michael A. Irvine et al. · 2022 · Epidemics
49. Modeling the Impact of Vaccination on COVID-19 and Its Delta and Omicron Variants
    Jianbo Wang, Yin-Chi Chan, Ruiwu Niu, Eric W. M. Wong, Michaël Antonie van Wyk · 2022 · Viruses
50. Modelling the unexpected dynamics of COVID-19 in Manaus, Brazil
    Daihai He, Yael A. Artzy‐Randrup, Salihu S. Musa, Tiago Gräf, Felipe Gomes Naveca, Lewi Stone · 2024 · Infectious Disease Modelling
51. Age-targeted dose allocation can halve COVID-19 vaccine requirements
    Michael T. Meehan, Daniel Cocks, Jamie M. Caldwell, James McCracken Trauer, Adeshina Israel Adekunle, Romain R. Ragonnet, Emma Sue McBryde · 2020 · medRxiv
52. Modelling the spread of SARS-CoV-2 pandemic - Impact of lockdowns & interventions
    Manindra Agrawal, Madhuri Kanitkar, Mathukumalli Vidyasagar · 2021 · The Indian Journal of Medical Research
53. Model-based analysis on social acceptability and feasibility of a focused protection strategy against the COVID-19 pandemic
    Takashi Akamatsu, Takeshi NAGAE, Minoru Osawa, Koki Satsukawa, Takara Sakai, Daijiro MIZUTANI · 2021 · Scientific Reports
54. The New Totalitarians: The Swedish COVID-19 strategy and the implications of consensus culture and media policy for public health
    Martin Lindström · 2021 · SSM - Population Health
55. Vaccine Hesitancy of Health-Care Workers: Another Challenge in the Fight Against COVID-19 in Istanbul
    Sarper Yılmaz, Figen Unal Colak, Erdal Yılmaz, Rohat Ak, Nihat Müjdat Hökenek, mehmet mustafa altıntaş · 2021 · Disaster Medicine and Public Health Preparedness
56. Scientific Models and Decision Making
    Eric B. Winsberg, Stephanie S. Harvard · 2024 · Cambridge University Press eBooks
57. Control of COVID-19 outbreak using an extended SEIR model
    Sean T. McQuade, Ryan Weightman, Nathaniel J. Merrill, Aayush Yadav, Emmanuel Trélat, Sarah Allred, Benedetto Piccoli · 2021 · Mathematical Models and Methods in Applied Sciences
58. Estimating the transmission advantage of the D614G mutant strain of SARS-CoV-2, December 2019 to June 2020
    Kathy S. M. Leung, Yao Pei, Gabriel Matthew Leung, Tommy Tsan‐Yuk Lam, Joseph Tsz Kei Wu · 2021 · Eurosurveillance
59. Herd immunity and epidemic size in networks with vaccination homophily
    Takayuki Hiraoka, Abbas K. Rizi, Mikko Kivelä, Jari Saramäki · 2022 · Physical review. E
60. COVID-19 Vaccine Hesitancy Prevalence and Predictors among the Students of Jazan University, Saudi Arabia Using the Health Belief Model: A Cross-Sectional Study
    Husameldin Elsawi Khalafalla, Maria Zenaida Tumambeng, Majidah Hussain Asiri Halawi, Enas Mohammed Ali Masmali, Thekra Badr Mohammed Tashari, Fatimah H Arishi, Roaa Hassan Mohammed Shadad, Sarah Zaki Abdullah Alfaraj, Shroog Mohammed Ali Fathi, Mohamed Salih Mahfouz · 2022 · Vaccines
61. Public health and expert failure
    Roger G. Koppl · 2021 · Public Choice
62. COVID-19 Vaccines in Older Adults
    Chih‐Kuang Liang, Wei‐Ju Lee, Li‐Ning Peng, Lin‐Chieh Meng, Fei‐Yuan Hsiao, Liang‐Kung Chen · 2022 · Clinics in Geriatric Medicine
63. Control of COVID‐19 Outbreaks under Stochastic Community Dynamics, Bimodality, or Limited Vaccination
    Björn Goldenbogen, Stephan O. Adler, Oliver Bodeit, Judith A. H. Wodke, Ximena Escalera‐Fanjul, Aviv Korman, Maria Krantz, Lasse Bonn, Rafael Morán‐Torres, Johanna Haffner et al. · 2022 · Advanced Science
64. COVID-19 vaccine hesitancy worldwide and its associated factors: a systematic review and meta-analysis
    Matin Baghani, Farzan Fathalizade, Amir Hossein Loghman, Noosha Samieefar, Farbod Ghobadinezhad, Ronak Rashedi, Hediyeh Baghsheikhi, Fatemeh Sodeifian, Milad Rahimzadegan, Meisam Akhlaghdoust · 2023 · Science in One Health
65. Dynamics of the COVID-19 epidemic in Ireland under mitigation
    Bernard Cazelles, Benjamin Nguyen-Van-Yen, Clara Champagne, Catherine Maria Comiskey · 2021 · BMC Infectious Diseases
66. Age-Stratified COVID-19 Spread Analysis and Vaccination: A Multitype Random Network Approach
    Xianhao Chen, Guangyu Zhu, Lan Zhang, Yuguang Michael Fang, Linke Guo, Xinguang Chen · 2021 · IEEE Transactions on Network Science and Engineering
67. What Lessons can Be Learned From the Management of the COVID-19 Pandemic?
    Gerry A. Quinn, Ronan Connolly, Coilín Oscar ÓhAiseadha, Paul Dylan Hynds, Philipp Bagus, Ronald B. Brown, Carlos F. Cáceres, C. E. H. Craig, Michael Connolly, José L. Domingo et al. · 2025 · International Journal of Public Health
68. Assessment of the Herd Immunity to SARS-CoV-2 among the Population of the Leningrad Region during the COVID-19 Epidemic
    A. Yu. Popova, Elena B. Ezhlova, Albina A. Melnikova, O. A. Historik, O. S. Mosevich, Liudmila V. Lyalina, В. С. Смирнов, M. A. Cherny, N. S. Balabysheva, I. S. Loginova et al. · 2020 · Problems of Particularly Dangerous Infections
69. ‘Dark matter’, second waves and epidemiological modelling
    Karl John Friston, Anthony M de L Costello, Deenan Pillay · 2020 · BMJ Global Health
70. Association of Lower Socioeconomic Status and SARS-CoV-2 Positivity in Los Angeles, California
    Lao‐Tzu Allan‐Blitz, Cameron S. Goldbeck, Fred Hertlein, Isaac Turner, Jeffrey David Klausner · 2021 · Journal of Preventive Medicine and Public Health
71. Using Proper Mean Generation Intervals in Modeling of COVID-19
    Xiujuan Tang, Salihu S. Musa, Shi Zhao, Shujiang Mei, Daihai He · 2021 · Frontiers in Public Health
72. An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations
    Bülent Kantarcıoğlu, Omer Iqbal, Joseph Lewis, Charles A. Carter, Meharvan Singh, Fabio A. Lievano, Mark A. Ligocki, Walter P Jeske, Cafer Adıgüzel, Grigoris Gerotziafas et al. · 2022 · Clinical and Applied Thrombosis/Hemostasis
73. Effect of vaccination patterns and vaccination rates on the spread and mortality of the COVID-19 pandemic
    Yi-Tui Chen · 2022 · Health Policy and Technology
74. New trends on the systems approach to modeling SARS-CoV-2 pandemics in a globally connected planet
    Giulia Bertaglia, Andrea Bondesan, Diletta Burini, Raluca Eftimie, Lorenzo Pareschi, Giuseppe Toscani · 2024 · Mathematical Models and Methods in Applied Sciences
75. High Frequency and Prevalence of Community-Based Asymptomatic SARS-CoV-2 Infection
    Lao‐Tzu Allan‐Blitz, Isaac Turner, Fred Hertlein, Jeffrey David Klausner · 2020 · medRxiv
76. Preparing for a Pandemic: Accelerating Vaccine Availability
    Amrita Ahuja, Susan Carleton Athey, Arthur Baker, Eric B. Budish, Juan Camilo Castillo, Rachel Glennerster, Scott Duke Kominers, Michael R. Kremer, Jean Nahrae Lee, Canice J. Prendergast et al. · 2021 · National Bureau of Economic Research
77. Viruses That Can and Cannot Coexist With Humans and the Future of SARS-CoV-2
    Yuki Furuse, Hitoshi Oshitani · 2020 · Frontiers in Microbiology
78. Incorporating false negative tests in epidemiological models for SARS-CoV-2 transmission and reconciling with seroprevalence estimates
    Rupam Bhattacharyya, Ritoban Kundu, Ritwik Bhaduri, Debashree Ray, Lauren J. Beesley, Maxwell Salvatore, Bhramar Mukherjee · 2021 · Scientific Reports
79. Validation of the COVID-19 Disbelief Scale: Conditional indirect effects of religiosity and COVID-19 fear on intent to vaccinate
    Stephen Bok, Daniel E. Martin, Maria Lee · 2021 · Acta Psychologica
80. Investigating the intention to receive the COVID-19 vaccination in Macao: implications for vaccination strategies
    Carolina Oi Lam Ung, Hu Yuanjia, Hao Hu, Ying Bian · 2022 · BMC Infectious Diseases
81. Initial SARS-CoV-2 Vaccination Uptake in a Correctional Setting: Cross-sectional Study
    Justin Berk, Matthew Murphy, Philip A. Chan, Kimberly Kane, Josiah D. Rich, Lauren Brinkley‐Rubinstein · 2021 · JMIRx Med
82. A novel compartmental model to capture the nonlinear trend of COVID-19
    Somayeh Bakhtiari Ramezani, Amin Amirlatifi, Shahram Rahimi · 2021 · Computers in Biology and Medicine
83. Managing host-parasite interactions in humans and wildlife in times of global change
    Konstans Wells, Robin J. Flynn · 2022 · Parasitology Research
84. How Much Testing and Social Distancing is Required to Control COVID-19? Some Insight Based on an Age-Differentiated Compartmental Model
    Sara Grundel, Stefan Heyder, Thomas Hotz, Tobias K. S. Ritschel, Philipp Sauerteig, Karl Worthmann · 2022 · SIAM Journal on Control and Optimization
85. A COVID-19 Epidemic Model Predicting the Effectiveness of Vaccination in the US
    Glenn F. Webb · 2021 · Infectious Disease Reports
86. The Impact of Contact Structure and Mixing on Control Measures and Disease-Induced Herd Immunity in Epidemic Models: A Mean-Field Model Perspective
    Francesco Di Lauro, Luc Berthouze A, Matthew D. Dorey, Joel C. Miller, Istvan Zoltan Kiss · 2021 · Bulletin of Mathematical Biology
87. Diverse Local Epidemics Reveal the Distinct Effects of Population Density, Demographics, Climate, Depletion of Susceptibles, and Intervention in the First Wave of COVID-19 in the United States
    Niayesh Afshordi, Benjamin P. Holder, Mohammad Bahrami, Daniel Lichtblau · 2021 · Fields Institute communications
88. An Ultrametric Random Walk Model for Disease Spread Taking into Account Social Clustering of the Population
    Andrei Yu. Khrennikov, Klaudia Oleschko L. · 2020 · Entropy
89. COVID-19: Second Wave or Multiple Peaks, Natural Herd Immunity or Vaccine – We Should be Prepared
    Rima Moghnieh, Dania Abdallah, Abdul Rahman Bizri · 2020 · Disaster Medicine and Public Health Preparedness
90. Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout
    Bimandra Adiputra Djaafara, Charles Whittaker, Oliver John Watson, Robert Verity, Nicholas F. Brazeau, Widyastuti WİDYASTUTİ, Dwi Oktavia, Verry Adrian, Ngabila Salama, Sangeeta Bhatia et al. · 2021 · BMC Medicine
91. Selective sweeps in SARS-CoV-2 variant competition
    Laura Boyle, Sofia Hletko, Jenny Huang, June Lee, Gaurav Pallod, Hwai-Ray Tung, Richard T Durrett · 2022 · Proceedings of the National Academy of Sciences
92. Final size and convergence rate for an epidemic in heterogeneous populations
    Luís Neves de Almeida, Pierre‐Alexandre Bliman, Grégoire Nadin B, Benoît Perthame B, Nicolas Vauchelet · 2021 · Mathematical Models and Methods in Applied Sciences
93. Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting
    Ellen C. Hughes, Julien A R Amat, Joanne Haney, Yasmin A. Parr, Nicola A. Logan, Norah E. Palmateer, Sema Nickbakhsh, Antonia Ying Wai Ho, Peter Cherepanov, Annachiara Rosa et al. · 2020 · The Journal of Infectious Diseases
94. Spatial‐SIR with network structure and behavior: Lockdown rules and the Lucas critique
    Alberto Bisin, Andrea Moro · 2022 · Journal of Economic Behavior & Organization
95. Reconciling epidemiological models with misclassified case-counts for SARS-CoV-2 with seroprevalence surveys: A case study in Delhi, India
    Rupam Bhattacharyya, Ritwik Bhaduri, Ritoban Kundu, Maxwell Salvatore, Bhramar Mukherjee · 2020 · medRxiv
96. SARS‐CoV ‐2 infection in India bucks the trend: Trained innate immunity?
    Sreedhar Chinnaswamy · 2020 · American Journal of Human Biology
97. Potential impact of individual exposure histories to endemic human coronaviruses on age-dependent severity of COVID-19
    Francesco Pinotti, Paul S. Wikramaratna, Uri Obolski, Robert Stephen Paton, Daniel Santa Cruz Damineli, Luíz Carlos Júnior Alcântara, Marta Giovanetti, Sunetra Gupta, José Lourenço · 2021 · BMC Medicine
98. Big data technology in infectious diseases modeling, simulation, and prediction after the COVID-19 outbreak
    Honghao Shi, Jingyuan Wang, Jiawei Cheng, Xiaopeng Qi, Hanran Ji, Claudio José Struchiner, Daniel Antunes Maciel Villela, Karamov Ev, Ali S. Turgiev · 2023 · Intelligent Medicine
99. A mathematical model with numerical simulations for malaria transmission dynamics with differential susceptibility and partial immunity
    Stéphane Yanick TCHOUMI, Herieth Rwezaura, Jean M. Tchuenche · 2023 · Healthcare Analytics
100. Policies on children and schools during the SARS-CoV-2 pandemic in Western Europe
     Antoni Soriano‐Arandes, Ana Brett, Danilo Buonsenso, Louise Emilsson, Isabel de la Fuente Garcia, Despοina Gkentzi, Otto Helve, Kasper P. Kepp, Maria Mossberg, Taulant Muka et al. · 2023 · Frontiers in Public Health